Tocilizumab Is Highly Active for Severe Steroid-Refractory Acute Graft-Versus-Host Disease of the Gastrointestinal Tract
Alex Ganetsky(Hospital of the University of Pennsylvania), David Porter(University of Pennsylvania), Selina M. Luger(University of Pennsylvania), James K. Mangan(UC San Diego Health System), Adam D. Cohen(Penn Center for AIDS Research), Edward A. Stadtmauer(University of Pennsylvania), Saar Gill(Parker Institute for Cancer Immunotherapy), Jacqueline Smith(Roslin Institute), Alison W. Loren(University of Pennsylvania), Sarah K Kraus(Hospital of the University of Pennsylvania), Colleen Timlin(Hospital of the University of Pennsylvania), William R. Drobyski(Medical College of Wisconsin), Noelle V. Frey(Hospital of the University of Pennsylvania), Elizabeth O. Hexner(University of Pennsylvania), Daria V. Babushok(Hospital of the University of Pennsylvania)
Cited by 4
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
|Journal of Clinical Oncology|1997|1.3k